Dave Dixon
www.mendeley.com
0000-0001-7560-9521
Virginia Commonwealth University School of Pharmacy
9 papers found
Refreshing results…
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the obesity medicine association and the National Lipid Association 2024
Role of lipoprotein(a) in atherosclerotic cardiovascular disease: A review of current and emerging therapies
ACE-Inhibitors in Hypertension: A Historical Perspective and Current Insights
Systolic Blood Pressure Time in Target Range and Major Adverse Kidney and Cardiovascular Events
Factors associated with antihypertensive monotherapy among US adults with treated hypertension and uncontrolled blood pressure overall and by race/ethnicity, National Health and Nutrition Examination Survey 2013-2018
The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The CANA‐HF study
Combination therapy with once-weekly glucagon like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a case series
Evolving Role of Non-Statin Therapy for the Management of Dyslipidemia and Cardiovascular Risk Reduction: Past, Present, and Future
A review of PCSK9 inhibition and its effects beyond LDL receptors
Missing publications? Search for publications with a matching author name.